The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Gibson Neil W since 2013.
The trader's CIK number is 1555918.
At the time of the last reporting, Gibson Neil W was the Chief Scientific Officer of Tcr2 Therapeutics Inc.. (stock ticker symbol TCRR).
Also see all insider trading activities at Tcr2 Therapeutics Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2020 | TCRR | 0 | $0 | 79,640 | $525,175 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2015 | RGLS | 0 | $0 | 80,000 | $1,465,600 | 0 | $0 |
| 2014 | RGLS | 0 | $0 | 52,500 | $515,257 | 82,500 | $149,676 |
| 2013 | RGLS | 0 | $0 | 0 | $0 | 50,000 | $87,000 |
1. Tcr2 Therapeutics Inc. (TCRR)
2. Regulus Therapeutics Inc. (RGLS)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-03-19 | TCRR | Sale | 3,140 | 7.41 | 23,267 |
| 2020-03-20 | TCRR | Sale | 648 | 7.94 | 5,145 |
| 2020-03-13 | TCRR | Sale | 52,000 | 6.52 | 338,884 |
| 2020-03-16 | TCRR | Sale | 17,723 | 6.60 | 117,042 |
| 2020-03-17 | TCRR | Sale | 3,009 | 6.49 | 19,528 |
| 2020-03-18 | TCRR | Sale | 3,120 | 6.83 | 21,309 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2015-01-28 | RGLS | Sale | 80,000 | 18.32 | 1,465,600 |
| 2014-11-28 | RGLS | Sale | 2,500 | 19.21 | 48,037 |
| 2014-11-28 | RGLS | Option Ex | 2,500 | 1.74 | 4,350 |
| 2014-10-29 | RGLS | Option Ex | 2,500 | 1.74 | 4,350 |
| 2014-10-29 | RGLS | Sale | 2,500 | 19.59 | 48,967 |
| 2014-10-22 | RGLS | Option Ex | 3,300 | 1.74 | 5,742 |
| 2014-10-22 | RGLS | Sale | 3,300 | 14.44 | 47,645 |
| 2014-09-11 | RGLS | Option Ex | 2,000 | 1.74 | 3,480 |
| 2014-09-12 | RGLS | Option Ex | 2,200 | 1.74 | 3,828 |
| 2014-09-11 | RGLS | Sale | 2,000 | 8.01 | 16,010 |
| 2014-09-12 | RGLS | Sale | 2,200 | 8.01 | 17,617 |
| 2014-07-01 | "RGLS" | Option Ex | 2,500 | 1.74 | 4,350 |
| 2014-07-01 | "RGLS" | Sale | 2,500 | 8.10 | 20,259 |
| 2014-06-17 | "RGLS" | Option Ex | 5,000 | 1.74 | 8,700 |
| 2014-06-17 | "RGLS" | Sale | 5,000 | 8.04 | 40,225 |
| 2014-04-09 | "RGLS" | Option Ex | 2,500 | 1.74 | 4,350 |
| 2014-04-09 | "RGLS" | Sale | 2,500 | 8.11 | 20,272 |
| 2014-03-06 | "RGLS" | Option Ex | 2,500 | 1.74 | 4,350 |
| 2014-03-06 | "RGLS" | Sale | 2,500 | 11.37 | 28,427 |
| 2014-02-05 | "RGLS" | Sale | 17,500 | 8.38 | 146,702 |
| 2014-02-06 | "RGLS" | Option Ex | 45,000 | 1.74 | 78,300 |
| 2014-02-05 | "RGLS" | Option Ex | 2,500 | 1.74 | 4,350 |
| 2014-01-21 | RGLS | Option Ex | 4,421 | 2.66 | 11,759 |
| 2014-01-21 | RGLS | Sale | 4,421 | 8.09 | 35,765 |
| 2014-01-17 | RGLS | Option Ex | 4,479 | 2.20 | 9,853 |
| 2014-01-17 | RGLS | Sale | 4,479 | 8.15 | 36,494 |
| 2014-01-16 | RGLS | Sale | 1,100 | 8.03 | 8,837 |
| 2014-01-16 | RGLS | Option Ex | 1,100 | 1.74 | 1,914 |
| 2013-02-04 | RGLS | Option Ex | 50,000 | 1.74 | 87,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Gibson Neil W (Chief Scientific Officer of Tcr2 Therapeutics Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.